Extended follow-up of antibody levels and antigen responsiveness after 2 Haemophilus influenzae type b conjugate vaccines (Q57769424)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431120%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

Extended follow-up of antibody levels and antigen responsiveness after 2 Haemophilus influenzae type b conjugate vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431120%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

main subject

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431120%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

S A Halperin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431120%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

R Guasparini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431120%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

W Meekison

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431120%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

C Pim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431120%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

L Barreto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431120%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

English

0 references

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431120%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431120%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431120%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

2 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431120%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

240-245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431120%20AND%20SRC:MED&resulttype=core&format=json

Eradication of Haemophilus influenzae type b disease in southern California. Kaiser-UCLA Vaccine Study Group

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Immunisation of infants in Iceland against Haemophilus influenzae type b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Predicted disappearance of Haemophilus influenzae type b meningitis in Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Preventing Haemophilus influenzae meningitis: Germany's experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Polysaccharide-protein conjugates: a new generation of vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Immunogenicity of Haemophilus influenzae type b tetanus toxoid conjugate vaccine in young infants. The Kaiser-UCLA Vaccine Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Study of booster doses of two Haemophilus influenzae type b conjugate vaccines including their interchangeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Epidemiology of invasive Haemophilus influenzae type b disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

The impact of conjugate vaccine on carriage of Haemophilus influenzae type b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Evaluation of booster doses of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in 18-month-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

A quantitative immunochemical measure of the primary interaction between I BSA and antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Serum antibodies in six-year-old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

Molecular characteristics of Haemophilus influenzae causing invasive disease during the period of vaccination in Switzerland: analysis of strains isolated between 1986 and 1993.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Antibodies against Haemophilus influenzae type b and tetanus in infants after subcutaneous vaccination with PRP-T/diphtheria, or PRP-OMP/diphtheria-tetanus vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970028-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(99)70028-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431120%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference